Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.63
-0.24 (-2.43%)
Jun 8, 2026, 4:09 PM HKT

HKG:2096 Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, HKG:2096 stock has a consensus rating of "Strong Buy" and an average price target of $17.83. The average 1-year stock price forecast is 85.15% higher than the current stock price, while the lowest is $12.40 (+28.76%) and the highest is $21.63 (+124.61%).

Price Target: $17.83 (+85.15%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$12.40$17.83$17.86$21.63
Change+28.76%+85.15%+85.46%+124.61%
* Price targets were last updated on Mar 31, 2026.

Analyst Ratings

The average analyst rating for HKG:2096 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy444445
Buy000011
Hold111111
Sell000000
Strong Sell000000
Total555567

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Bank of China
No rating
Bank of China
Buy
Maintains
$17.00
BuyMaintains$17.00+76.53%Mar 31, 2026
Unknown Analyst
BOCOM International Holdings Company
No rating
BOCOM International Holdings Company
Buy
Maintains
$17.70
BuyMaintains$17.70+83.80%Mar 30, 2026
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$19.82$21.32
BuyMaintains$19.82$21.32+121.39%Mar 30, 2026
Unknown Analyst
Sinolink Securities
No rating
Sinolink Securities
Buy
Maintains
$20.16
BuyMaintains$20.16+109.35%Dec 27, 2025

Financial Forecast

Revenue This Year
10.12B
from 7.73B
Increased by 30.87%
Revenue Next Year
11.41B
from 10.12B
Increased by 12.80%
EPS This Year
5.15
from 3.54
Increased by 45.18%
EPS Next Year
5.18
from 5.15
Increased by 0.71%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
5.00B6.32B6.61B6.64B7.73B10.12B
Revenue Growth
10.89%26.49%4.49%0.42%16.52%30.87%
Gross Profit
3.92B5.00B4.98B5.32B6.31B8.28B
Gross Margin
78.40%79.01%75.43%80.25%81.61%81.85%
Operating Income
233.33M606.34M710.84M1.12B1.42B2.07B
Net Income
1.51B930.87M714.76M722.00M1.34B1.66B
EPS
----3.545.15
EPS Growth
----77.34%45.18%
Forward PE
26.6329.0412.1114.3516.581.62
Dividend / Share
0.150.160.160.160.182.42
Dividend Growth
-6.67%--12.50%1,243.43%
Free Cash Flow
438.89M175.48M-1.05B429.35M776.72M618.19M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High10.5B
Avg10.1B
Low9.6B

Revenue Growth

Revenue Growth202620272028
High
35.5%
Avg
30.9%
Low
24.6%

EPS Forecast

EPS202620272028
High7.44
Avg5.15
Low4.27

EPS Growth

EPS Growth202620272028
High
110.0%
Avg
45.2%
Low
20.6%